Overview Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies Status: Recruiting Trial end date: 2024-11-01 Target enrollment: Participant gender: Summary In this study, we investigate the safety and efficacy of topical sirolimus in the treatment of superficial complicated vascular anomolies. Phase: Phase 4 Details Lead Sponsor: Children's Hospital of Fudan UniversityTreatments: Sirolimus